Opioid-related adverse drug events are common among patients undergoing hospital-based invasive procedures and are associated with worse patient clinical and cost outcomes, a recent study found. The retrospective study of clinical and administrative data included 135,379 adult patients (67.5% female) and examined the incidence of opioid-related adverse drug events (ORADEs) in patients undergoing hospital-based surgical and endoscopic procedures. Researchers found:
- 14,386 (10.6%) patients in the study population experienced at least 1 ORADE.
- Patients with ORADEs were more likely to be older, of white race/ethnicity, and male and have more comorbidities.
- Patients with ORADEs received a higher total dose of opioids and for a longer duration.
- ORADEs were associated with increased inpatient mortality, greater likelihood of discharge to another care facility, prolonged length of stay, high cost of hospitalization, and higher rate of 30-day readmission.
Shafi S, Collinsworth AW, Copeland LA, et al. Association of opioid-related adverse drug events with clinical and cost outcomes among surgical patients in a large integrated health care delivery system. [Published online ahead of print May 23, 2018]. JAMA Surg. doi:10.1001/jamasurg.2018.1039.
This Week's Must Reads
Must Reads in Pain
Sleep Disturbance and Chronic Pain Intensity, Clin J Pain; ePub 2019 Mar 25; Burgess, et al
Dual Receipt of Rx Opioids & Overdose Death, Ann Intern Med; ePub 2019 Mar 12; Moyo, et al
Opioid-Related Mortality in US by Opioid Type, JAMA Netw Open; 2019 Feb 22; Kiang, et al